Cooper Laurence James Neil 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 8, 2019
Insider Transaction Report
Form 4
Cooper Laurence James Neil
Chief Executive Officer
Transactions
- Award
Common Stock
2019-01-06+446,428→ 1,964,503 total - Award
Employee Stock Option (right to buy)
2019-01-06+531,813→ 531,813 totalExercise: $2.24Exp: 2029-01-06→ Common Stock (531,813 underlying) - Award
Common Stock
2019-01-06+337,266→ 1,518,075 total - Tax Payment
Common Stock
2019-01-06$2.24/sh−165,178$369,999→ 1,799,325 total
Footnotes (4)
- [F1]112,422 shares shall vest on each of 12/31/2019, 12/31/2020 and 12/31/2021.
- [F2]Pursuant to the Issuer's option plan, the Reporting Person elected to receive fully vested shares of Common Stock in lieu of a cash bonus.
- [F3]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grant.
- [F4]1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2018.